Alzheimer's disease

Neurotrope stock tumbles again on Alzheimer's data
Neurotrope stock tumbles again on Alzheimer's data
BioPharma Dive
Neurotrope BioScience
Alzheimer's disease
Flag link:
New data from Alzheon shows long-term benefit for Alzheimer's
New data from Alzheon shows long-term benefit for Alzheimer's
BioPharma Dive
Alzheon
Alzheimer's disease
ALZ-801
Flag link:
5 trends shaping Alzheimer's drug development
5 trends shaping Alzheimer's drug development
BioPharma Dive
Alzheimer's disease
drug development
Flag link:
Big Pharma VCs jump in to back a $63M mission to tackle a genetic driver of Alzheimer’s
Big Pharma VCs jump in to back a $63M mission to tackle a genetic driver of Alzheimer’s
Endpoints
Big Pharma
venture capital
Alzheimer's disease
Flag link:
Alzheon says data backs potential of Alzheimer's candidate
Alzheon says data backs potential of Alzheimer's candidate
PM Live
Alzheon
Alzheimer's disease
tramiprosate
Flag link:
Alzheimer’s Drug Pipeline Analysis: Have We Hit Peak Amyloid?
Alzheimer’s Drug Pipeline Analysis: Have We Hit Peak Amyloid?
Xconomy
Alzheimer's disease
anti-amyloid
solanezumab
Eli Lilly
Biogen
aducanumab
RVT-101
Flag link:
Alzheimer's Affects Twice As Many People As Estimated, Says New Study
Alzheimer's Affects Twice As Many People As Estimated, Says New Study
Forbes
Alzheimer's disease
Flag link:
In small Alzheimer’s study, hints of modest benefit from unusual drug
In small Alzheimer’s study, hints of modest benefit from unusual drug
Stat
Alzheimer's disease
Neurotrope BioScience
Bryostatin-1
Flag link:
Novartis Tests New Alzheimer's Drugs on People Who Don't Have the Disease
Novartis Tests New Alzheimer's Drugs on People Who Don't Have the Disease
FOX Business
Novartis
Alzheimer's disease
Flag link:
A company developing a drug to treat Alzheimer's disease just got a new CEO — and the stock is jumping
A company developing a drug to treat Alzheimer's disease just got a new CEO — and the stock is jumping
Yahoo/Business Insider
Alzheimer's disease
David Hung
Pharma CEOs
Axovant Sciences
Flag link:
Alzheimer's $250B Cost Could Break Medicare
Alzheimer's $250B Cost Could Break Medicare
Forbes
Alzheimer's disease
Medicare
Flag link:
Roche is bringing back gantenerumab from the dead, taking another stab at Alzheimer’s PhIII
Roche is bringing back gantenerumab from the dead, taking another stab at Alzheimer’s PhIII
Endpoints
Roche
gantenerumab
Alzheimer's disease
clinical trials
Flag link:
Big Pharma Is Losing a Fortune Trying to Cure Alzheimer's
Big Pharma Is Losing a Fortune Trying to Cure Alzheimer's
Bloomberg
Alzheimer's disease
drug development
Roche
Merck
Eli Lilly
Biogen
Flag link:
Thumped by the FDA, Accera’s attempt to do a serious Alzheimer’s PhIII ends with a flop
Thumped by the FDA, Accera’s attempt to do a serious Alzheimer’s PhIII ends with a flop
Endpoints
FDA
Accera
Alzheimer's disease
clinical trials
Axona
medical food
Flag link:
Roche to start new trial of AC Immune drug against Alzheimer's
Roche to start new trial of AC Immune drug against Alzheimer's
Yahoo/Reuters
Roche
AC Immune
Alzheimer's disease
clinical trials
crenezumab
Flag link:
Merck stopping late stage study as another Alzheimer's drug fails
Merck stopping late stage study as another Alzheimer's drug fails
Yahoo/Reuters
Merck
Alzheimer's disease
verubecestat
clinical trials
Flag link:
Lundbeck reads last rites on another failed PhIII Alzheimer’s program
Lundbeck reads last rites on another failed PhIII Alzheimer’s program
Endpoints
Lundbeck
Otsuka
Alzheimer's disease
idalopirdine
Flag link:
AbbVie’s Anti-Tau Antibody Enters Phase II Clinical Trials for Alzheimer’s Disease
AbbVie’s Anti-Tau Antibody Enters Phase II Clinical Trials for Alzheimer’s Disease
Xtalks
AbbVie
clinical trials
anti-tau antibodies
Alzheimer's disease
ABBV-8E12
Flag link:
Five 'Big Idea' Biotech Trends to Watch in 2017
Five 'Big Idea' Biotech Trends to Watch in 2017
Forbes
biotech
protein targets
Alzheimer's disease
Flag link:
Alzheimer's disease psychosis drug clears mid-stage study -Acadia
Alzheimer's disease psychosis drug clears mid-stage study -Acadia
Yahoo/Reuters
Acadia
Alzheimer's disease
pimavanserin
Flag link: